Clinicians work under guidance meant to reduce risky prescribing, and recent data show overall use of these medications is falling. Still, people already showing cognitive problems are more likely to be prescribed them, and records often lack a clear medical reason for starting the drugs. That gap between guidance and practice points to system-level issues: how decisions are documented, how families and doctors weigh trade-offs, and how care teams support safer alternatives.
This topic matters because preserving mobility, clarity of mind, and dignity are central to human potential as we grow older. Learning how and why certain medications keep being used could reveal practical fixes in clinics and homes. Follow the link to explore the study and consider what changes might make everyday life safer for millions living with dementia.
Despite longstanding guidelines, many dementia patients are still prescribed brain-altering medications that can raise the risk of falls and confusion. A new study shows that while prescribing has decreased overall, people with cognitive impairment remain more likely to receive these drugs. In many cases, there was no documented medical justification. The results suggest that medication safety remains a serious concern in dementia care.
